Inventor · San Mateo, CA, US

Michael Sangi

22Patents
5h-index
91Co-inventors
68Inventor score

Filing activity: Jun 23, 2011 → Dec 21, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8486938B2 Pyrazolo[1,5-a]pyrimidines for antiviral treatment Chemistry; Metallurgy 14 Active
US9376441B2 Substituted pyrrolidines as SYK inhibitors Chemistry; Metallurgy 13 Active
US8809330B2 Pyrazolo[1,5-A]pyrimidines for antiviral treatment Chemistry; Metallurgy 9 Active
US8980878B2 Compounds and methods for antiviral treatment Chemistry; Metallurgy 8 Active
US8946238B2 Pyrazolo[1,5-A]pyrimidines as antiviral agents Chemistry; Metallurgy 6 Active
US9238039B2 Pyrazolo[1,5-A]pyrimidines for antiviral treatment Chemistry; Metallurgy 5 Active
US10005774B2 Syk inhibitors Chemistry; Metallurgy 4 Active
US9296782B2 Inhibitors of hepatitis C virus Human Necessities 4 Active
US11136290B2 Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives Emerging Cross-Sectional Technologies 4 Active
US9278975B2 Pyrazolo[1,5-A]pyrimidines as antiviral agents Chemistry; Metallurgy 2 Active
US9655944B2 Inhibitors of hepatitis C virus Human Necessities 2 Active
US9504689B2 Compounds and methods for antiviral treatment Chemistry; Metallurgy 2 Active
US11976083B2 Inhibitors of peptidylarginine deiminases Chemistry; Metallurgy 1 Active
US10335409B2 Inhibitors of hepatitis C virus Human Necessities 1 Active
US9440991B2 Synthesis of an antiviral compound Emerging Cross-Sectional Technologies 1 Active
US11878965B2 Inhibitors of peptidylarginine deiminases Chemistry; Metallurgy 1 Active
US10174038B2 Compounds and methods for antiviral treatment Chemistry; Metallurgy 0 Active
US12240862B2 Inhibitors of peptidylarginine deiminases Chemistry; Metallurgy 0 Active
US9957275B2 Pyrazolo[1,5-A]pyrimidines for antiviral treatment Chemistry; Metallurgy 0 Active
US10030033B2 Synthesis of an antiviral compound Emerging Cross-Sectional Technologies 0 Active
US12049439B2 Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives Emerging Cross-Sectional Technologies 0 Active
US10603318B2 Inhibitors of hepatitis C virus Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.